Piramal Pharma Merger & Restructuring Worth ₹76 Cr

Piramal Pharma Capital Structure Change

HDFC Mutual Fund schemes reduced their Piramal Pharma stake by 2.027% via open market sale on 28 October 2026. Holding fell from 7.015% to 4.988%.

Piramal Pharma Investor Presentation: Key Takeaways

Q2FY27 revenue ₹2,617 Cr (+28% YoY), EBITDA margin 14.7% (+372 bps), PAT ₹5 Cr vs loss of ₹99 Cr. FY27 revenue growth outlook raised to 19-20%.

Piramal Pharma Results Update

Piramal Pharma released its Q2/H1 FY27 press release reporting revenue of Rs. 2,617 crore for Q2 and Rs. 4,887 crore for H1, with EBITDA up 72%. The filing also upgrades FY27 revenue growth guidance to 19–20%.

Piramal Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹5 Cr

Piramal Pharma Ltd reported revenue from operations of ₹2,617 Cr (+28.1% YoY) and net profit of ₹5 Cr for Q2 FY27.

Key figure

Net profit ₹5 Cr

Piramal Pharma Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026. The report details equity distribution among promoters and public shareholders.

Piramal Pharma Board Meeting Date

Piramal Pharma Limited has scheduled a board meeting on October 27, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.

AAA Technologies Merger & Restructuring

AAA Technologies approved four wholly owned subsidiaries in Singapore, Mauritius, Dubai and India. Each entity is in IT security, cybersecurity and technology services.

Tirupati Starch & Chemicals Merger & Restructuring Worth ₹2.98 Cr

Tirupati Starch agreed to sell its Indore immovable property to Usha and Arpit Doshi for Rs 2.98 Crore. Completion is expected by 15 January 2027, subject to conditions.

Value

₹2.98 Cr

Execution

Completion expected on or before 15 January 2027

CFF Fluid Control Merger & Restructuring

CFF Fluid Control will form a 51% joint venture with TKMS Atlas Elektronik for anti-submarine warfare in India. No deal value is disclosed.

Trom Industries Merger & Restructuring Worth ₹0.02 Cr

Trom Industries plans to incorporate Trom Energy SPV Private Limited, a solar power subsidiary, holding 98%. The initial cash subscription is Rs 1,96,000 for 19,600 shares.

Value

₹0.02 Cr

Yasons Chemex Care Merger & Restructuring Worth ₹29.61 Cr

Yasons Chemex's subsidiary Rishit Polysurf LLP signed a slump sale agreement to sell its chemical manufacturing business to Vasudha Specialities Emulsifiers. Consideration is Rs.29.61 Crore in cash.

Value

₹29.61 Cr

Dhruv Consultancy Services Merger & Restructuring Worth ₹0.3 Cr

Dhruv Consultancy incorporated Valsang Drivehub Private Limited, subscribing to 55% for Rs.0.30 Crore. The subsidiary will execute a wayside amenities project under an NHLML award.

Value

₹0.30 Cr